Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2

It has been hypothesised that antiallergic medications (AAMs) like montelukast and levocetirizine both the two bitter chloro compounds could be repurposed either alone or combinedly as an antiviral against SARS-CoV-2, like chloroquine/hydroxychloroquine (CQ/HCQ), another two bitter chloro compounds....

Descripción completa

Detalles Bibliográficos
Autor principal: Bhattacharyya, Dipankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Letter to Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321662/
https://www.ncbi.nlm.nih.gov/pubmed/33254480
http://dx.doi.org/10.1016/j.mehy.2020.110046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321662/
https://www.ncbi.nlm.nih.gov/pubmed/33254480
http://dx.doi.org/10.1016/j.mehy.2020.110046

Ejemplares similares